Aptorum Group announces collab between DiamiR, Instant NanoBiosensors

Aptorum Group (APM), DiamiR Biosciences, and Instant NanoBiosensors announced a collaboration between DiamiR and INB to validate INB’s automated APOE testing platform for clinical use in DiamiR’s CLIA-certified, CAP-accredited clinical laboratory. Tony Chung, Chairman of Instant NanoBiosensors, stated, “We view DiamiR Biosciences as a highly respected reference laboratory. We believe that completing this validation and implementing the service together will strengthen confidence in the INB platform, expand DiamiR’s validated service offerings, and establish a strong foundation for future collaboration and additional applications beyond APOE testing.”